Journals / Eurasian Journal of Emergency Medicine / 2014 / Cilt: 13 - Sayı: 1

Arrhythmogenic Right Ventricular Cardiomyopathy vs. Cardiac Sarcoidosis - A Tissue Diagnosis Makes All The Difference

Pages
30–32
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

However, an endovascular biopsy was taken from the right ventricle and tissue diagnosis was made of isolated cardiac sarcoidosis and corticosteroids were commenced.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is primarily an autosomal dominant structural abnormality where fibro fatty replacement of cardiac myocytes results in tachyarrhythmias and sudden death.
📊
Key Findings & Data:A 31 year old Irish male presented to a regional hospital with a one hour history of palpitations and mild chest discomfort.
💡
Conclusion & Impact:However, an endovascular biopsy was taken from the right ventricle and tissue diagnosis was made of isolated cardiac sarcoidosis and corticosteroids were commenced.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is primarily an autosomal dominant structural abnormality where fibro fatty replacement of cardiac myocytes results in tachyarrhythmias and sudden death. Sarcoidosis, on the other hand, is a multisystem granulomatous disease of unknown aetiology characterized by non-caseating granulomas in involved organs. ARVC can be mimicked both clinically and radiologically by cardiac sarcoidosis. In some cases differentiating the diagnoses is only made at biopsy or autopsy. A 31 year old Irish male presented to a regional hospital with a one hour history of palpitations and mild chest discomfort. Emergency department (ED) electrocardiograph (ECG) revealed ventricular tachycardia (VT). Direct current cardioversion of 150 kilojoules was given due to haemodynamic instability and resulted in reversion to normal sinus rhythm. Following this, he was treated as a non ST-segment elevation myocardial infarction and referred to a tertiary referral centre for coronary artery angiography. Normal angiography and echocardiogram prompted cardiac magnetic resonance imaging (MRI) which demonstrated right ventricular outflow tract scarring consistent with either a primary diagnosis of ARVC or cardiac sarcoidosis. Initially, a diagnosis of sarcoidosis was deemed less likely on the basis of normal laboratory findings and absence of other clinical manifestations of extra cardiac sarcoidosis. However, an endovascular biopsy was taken from the right ventricle and tissue diagnosis was made of isolated cardiac sarcoidosis and corticosteroids were commenced.

🔖

Cite This Article

RAMASUBBU, B. M., MURPHY, R. T. (2022). Arrhythmogenic Right Ventricular Cardiomyopathy vs. Cardiac Sarcoidosis - A Tissue Diagnosis Makes All The Difference. Eurasian Journal of Emergency Medicine, Cilt: 13 - Sayı: 1, 30–32. https://ajindex.com/articles/508235

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Gerull B, Heuser A, WichterT, Paul M, Basson CT, McDermott DA, et al. Mutations in the desmosomal protein plakophilin--2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004; 36: 162--4. [CrossRef] McKoy G, Protonotarios N, Crosby A,Tsatsopoulou A, Anastasakis A, Coo-- nar A, et al. Identification ofa deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy With palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000; 355: 21 19--24. [CrossRef] Sen--Chowdhry S, Syrris P, McKenna WJ. Role of Genetic Analysis in the Management of Patients with Arrhythmogenic Right Ventricular Dyspla-- sia/Cardiomyopathy. Am Coll Cardiol 2007; 50: 1813--21.[CrossRef] U.S Library of Medicine, Genetic Home Reference. Reviewed: May 2010. Published: January 30, 2012.
  2. Corrado D, Thiene G. Arrhythmogenic Right Ventricular Cardiomyopat-- hy/Dysplasia: Clinical Impact of Molecular Genetic Studies. Circulation 2006; 113: 1634--7. [CrossRef] Arrhythmogenic Right Ventricular Cardiomyopathy. NYU Langone Medical Centre, Cardiovascular genetics programme. http://www.med.nyu.edu/
  3. Sekhri V, Sanal S, Delorenzo LJ, Aronow WS, Maguire GP. Cardiac sarcoi-- dosis: comprehensive review. Arch Med Sci 201 1; 7: 546--54. [CrossRef] Mitchell DN, Du Bois RM, Oldershaw PJ. Cardiac sarcoidosis potenti-- ally fatal condition that needs expert assessment. BMJ 1997; 314: 320--1. [CrossRef] Ott P, Marcus FI, Sobonya RE, Morady F, Knight BP, Fuenzalida CE. Cardiac Sarcoidosis Masquerading as Right Ventricular Dysplasia. Pacing Clin Ele-- ctrophysiol 2003; 26: 1498--503. [CrossRef]